Lipella制药公司报告季度每股损失1.19美元,收入为17万美元。 Lipella Pharmaceuticals reported a quarterly loss of $1.19 per share, with revenue at $0.17 million.

Lipella制药公司报告说,最近季度每股损失1.19美元,收入17万美元。 Lipella Pharmaceuticals reported a loss of $1.19 per share for the latest quarter, with revenue of $0.17 million. 该公司的净负差为882.82%,股本回报为负,为192.33%。 The company's negative net margin was 882.82% and return on equity was negative at 192.33%. Lipella的重点是重新配制现有非专利药物,并正在为各种医疗条件开发LP-10、LP-310和LP-410等治疗方法。 Lipella focuses on reformulating existing generic drugs and is developing treatments like LP-10, LP-310, and LP-410 for various medical conditions. 该公司的股票在星期五以2.59美元开放。 The company's stock opened at $2.59 on Friday.